lunes, 14 de enero de 2019

CF Patients With F508del Mutations Show Improvement With Eluforsen, Trial Finds

CF Patients With F508del Mutations Show Improvement With Eluforsen, Trial Finds

Cystic Fibrosis News Today

Eluforsen Improves CFTR Protein Function in CF Patients with F508del Mutations, Phase 1 Trial Shows

 JANUARY 14, 2019
Jose Marques Lopes, PhDBY JOSE MARQUES LOPES, PHD
 
IN CYSTIC FIBROSIS, NEWS.
Eluforsen Improves CFTR Protein Function in CF Patients with F508del Mutations, Phase 1 Trial Shows
Publicado por en

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)